As with all injections, the treatment area might experience slight soreness, bruising, and redness
A typical FDA-approved regimen for pernicious anemia includes: 100 g IM/SC daily for 67 days Then every other day for 7 doses Then every 34 days for 23 weeks Followed by 100 g monthly for life Schedule follow-up and monitor progress Potassium levels should be monitored during the first 48 hours of treatment, as rapid red blood cell production may lead to hypokalemia and, rarely, sudden death
These effects were maintained for the first posttreatment (placebo) night
If you cant find 4-5 mm needles, 6-8 mm ones can also be suitable as long as you inject into an area with enough fat, such as around the belly button
There is no published human trial of the BPC-157 + TB-500 + GHK-Cu combination
PT-141 PT-141, also known as Bremelanotide, is a synthetic peptide developed from the peptide hormone Melanotan II